Conventional cancer screening was designed to detect the most common cancers in the general population. It was not designed for the individual, and it covers only a fraction of the more than 200 cancers that exist. Many cancers are still diagnosed at an advanced stage each year, when cure is often no longer possible.

PreOncology was founded by oncologists who spent decades on the wrong side of that timeline.

We treated patients after their cancer was found, often too late, often after it had spread, often after the window for early intervention had closed. We saw what worked: early-stage cancers are curable. Late-stage cancers usually are not.

The technology to detect cancer earlier now exists. But no one was integrating it. Patients received fragmented testing with no coordination. Results came back with no guidance on next steps. Primary care physicians were left to navigate a rapidly evolving landscape without the clinical infrastructure to do it rigorously.

We built what the field was missing: a personalized program that brings these technologies together, interprets them through an oncology lens, and delivers the oversight that cancer risk management requires.